EIF2A and prostate carcinoma: In prostate cancer, NIBAN1 is rapidly activated in response to ER stress by ATF4, either by stimulating eIF2α phosphorylation, via PERK, or by inhibiting eIF2α phosphorylation directly, via NIBAN1 (Figure 2A).